OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Entyvio Pen

vedolizumab

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Entyvio Pen
Proper name
vedolizumab
Licence type
351(a)
BLA number
761133
Applicant
Takeda Pharmaceuticals U.S.A., Inc.
Center
CDER
Presentations
1
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
108MG/0.68ML Injection Subcutaneous Autoinjector Rx September 27, 2023

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity